Free. Unsubscribe any time.
Arcellx, Inc. (ACLX)
Arcellx, Inc. filed 17 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 28 transactions and 84,805 shares. 9 carry the SEC's AFF10B5ONE flag; 8 name a plan only in a footnote. 4 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-01-20, came 64 days after the one before it (2025-11-17) and reports 3 transactions against 1 in the filing before it.
- The sales it reports total 6,000 shares, 5,660 more than the 340 in the filing before it.
- Its 17 plan statements rank 315th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 17 filings on file run from 2025-01-10 to 2026-01-20, and state 5 plan adoption dates, from 2023-12-18 to 2025-09-29.
Trades in Arcellx, Inc. 28
- Gilson Michelle — 2025-01-07 · S · 3,128 shares
- Gilson Michelle — 2025-01-07 · S · 1,546 shares
- Gilson Michelle — 2025-01-07 · S · 2,251 shares
- Gilson Michelle — 2025-01-07 · S · 2,327 shares
- Gilson Michelle — 2025-01-07 · S · 4,760 shares
- Gilson Michelle — 2025-01-08 · S · 3,997 shares
- Patel Kavita — 2025-01-14 · S · 800 shares
- Patel Kavita — 2025-01-14 · S · 400 shares
- Patel Kavita — 2025-01-14 · S · 300 shares
- Patel Kavita — 2025-02-04 · S · 1,500 shares
- Patel Kavita — 2025-02-25 · S · 1,500 shares
- Patel Kavita — 2025-03-18 · S · 1,500 shares
Adoption dates in Arcellx, Inc. 5
- 2023-12-18 — stated in 1 filing
- 2024-03-28 — stated in 8 filings
- 2025-03-21 — stated in 2 filings
- 2025-03-23 — stated in 5 filings
- 2025-09-29 — stated in 1 filing
Results prints in Arcellx, Inc. 4
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-05
Trades before a print in Arcellx, Inc. 1
- 2 days before the 2025-02-27 print — 2025-02-25 · S · Patel Kavita · 1,500 shares
- 9 days before the 2025-05-08 print — 2025-04-29 · S · Patel Kavita · 1,500 shares
- 21 days before the 2025-11-05 print — 2025-10-15 · S · Gilson Michelle · 5,364 shares
- 23 days before the 2025-02-27 print — 2025-02-04 · S · Patel Kavita · 1,500 shares
- 30 days before the 2025-05-08 print — 2025-04-08 · S · Patel Kavita · 1,500 shares
- 30 days before the 2025-11-05 print — 2025-10-06 · S · Gilson Michelle · 1,064 shares
- 33 days before the 2025-11-05 print — 2025-10-03 · S · Gilson Michelle · 4,882 shares
- 36 days before the 2025-11-05 print — 2025-09-30 · S · Heery Christopher · 5,300 shares
- 36 days before the 2025-11-05 print — 2025-09-30 · S · Heery Christopher · 14,204 shares
- 36 days before the 2025-11-05 print — 2025-09-30 · S · Heery Christopher · 1,530 shares
- 37 days before the 2025-11-05 print — 2025-09-29 · S · Heery Christopher · 73 shares
- 40 days before the 2025-11-05 print — 2025-09-26 · S · Heery Christopher · 12,396 shares
Interval to Arcellx, Inc.’s next reported results date
How the interval and sources are counted →
- 1within 5 days
- 2within 10 days
- 2shortest, days
- 2no later print
- Patel Kavita 2025-02-25 · S · 2 days before the 2025-02-27 print
- Patel Kavita 2025-04-29 · S · 9 days before the 2025-05-08 print
Adoption dates Arcellx, Inc. states
- 2023-12-18 in 1 filing
- 2024-03-28 in 8 filings
- 2025-03-21 in 2 filings
- 2025-03-23 in 5 filings
- 2025-09-29 in 1 filing
Filing text: “10b5-1 trading plan entered into by the Reporting Person on March 28, 2024”
Reported results dates on file
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-05
A proxy statement is on file for this company in the same window (2025-04-17), which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.